Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,432.00    -44.00 (-2.98%)
Bid:
1,430.00
Ask:
1,436.00
Spread: 6.00 (0.42%)
Market Cap: £490.28m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Significant Contract Wins

13 Feb 2018 07:00

RNS Number : 6550E
Craneware plc
13 February 2018
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Wins

 

13 February 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce two significant new contracts with hospital providers in the US. Both hospital providers are new customers to Craneware.

 

The first contract with a large blue chip healthcare provider, sees Craneware's Value Cycle products being deployed across this organisation's 20 hospitals. Craneware's solutions will be an integral part of this provider's major system change, helping to ensure revenue integrity during the initiative and beyond. This contract is expected to deliver c$5m of revenue over its initial multi-year term.

 

The second contract win with an innovative surgical hospital is for the provision of Craneware's suite of products as part of its strategic growth plans, deploying multiple Craneware solutions, including the Trisus Platform and Trisus Claims Informatics. This provider is focused on improving all aspects of its value cycle. This multi-year contract is expected to deliver c$3.5m of revenue over its initial term.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from these two contracts will be recognised over future periods, adding to the Group's long term visibility of revenue under contract, supporting ongoing financial performance.

 

Keith Neilson, CEO of Craneware plc, commented, "These contract wins confirm that the positive momentum and financial success we reported in the first half of the year has continued into the second half.

 

"This is further evidence of the strategic importance and value that Craneware's solutions can bring to all sizes and complexities of hospital healthcare providers, as they look to address the challenges they face with the ongoing evolution of the US Healthcare market.

 

"This continued momentum across the entire business, combined with the strength of our solution set, means we are well positioned to support our customers in the new era of value-based care and deliver increasing stakeholder value."

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn Fisher

 

 

 

 

 

 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGGUGUPUPRPWP
Date   Source Headline
15th May 20268:36 amRNSNotification of Major Holdings
13th May 20266:11 pmRNSNotification of Major Holdings
13th May 20261:50 pmRNSNotification of Major Holdings
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20265:11 pmRNSGrant of Share Options to Directors
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
27th Apr 202612:47 pmRNSNotification of Major Holdings
23rd Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSBlock Admission
13th Apr 202610:37 amRNSGrant of Share Option to PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:26 amRNSDividend Currency Election
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
4th Mar 20267:00 amRNSDirector's Acquisition of Shares
2nd Mar 20267:00 amRNSFY26 Interim Results
18th Feb 20263:49 pmRNSNotification of Major Holdings
9th Feb 20264:55 pmRNSNotification of Major Holdings
3rd Feb 20263:16 pmRNSNotification of Major Holdings
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
28th Nov 202511:31 amRNSDividend Currency Election
21st Nov 20251:51 pmRNSResult of AGM
21st Nov 20257:00 amRNSAGM Statement and Board Changes
20th Nov 20257:00 amRNSVesting of LTIP Awards and Total Voting Rights
13th Nov 202510:51 amRNSReduction of Capital effective
6th Nov 20253:41 pmRNSReduction of Capital confirmed
22nd Oct 20255:17 pmRNSAnnual Report, Notice of AGM, Directorate Change
22nd Oct 20259:24 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSBlock listing Interim Review
17th Sep 20257:00 amRNSGrant of Long Term Incentive Plan Awards
15th Sep 20257:00 amRNSFY25 Final Results
1st Sep 20257:00 amRNSBank Refinancing
20th Aug 20256:22 pmRNSResult of General Meeting - Replacement
20th Aug 20254:28 pmRNSResult of AGM
1st Aug 20254:35 pmRNSProposed Reduction of Capital
16th Jul 20257:00 amRNSFY25 Trading Update
12th Jun 20253:20 pmRNSForm 8.3 - Craneware plc
12th Jun 202511:55 amRNSForm 8.5 (EPT/RI) - Craneware PLC
11th Jun 20253:00 pmRNSForm 8.3 - Craneware PLC
11th Jun 20252:47 pmRNSForm 8.3 - CRANEWARE PLC
11th Jun 20252:40 pmGNWForm 8.3 - Craneware Plc
11th Jun 202512:02 pmGNWForm 8.3 - [CRANEWARE PLC - 10 06 2025] - (CGWL)
11th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.